FilingReader Intelligence
Concord Biotech passes EU GMP inspection at Gujarat facility
July 18, 2025 at 07:49 AM UTC•By FilingReader AI
Concord Biotech Limited successfully completed its European Union Good Manufacturing Practice (EU GMP) inspection at its Active Pharmaceutical Ingredient manufacturing facility in Dholka, Gujarat.
The inspection took place between July 14, 2025, and July 18, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:CONCORDBIO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Concord Biotech publishes news
Free account required • Unsubscribe anytime